Table 1 Demographic and clinical characteristics of RA patients.
From: Prevalence and impact of thyroid dysfunction in patients with rheumatoid arthritis
Age (years) (mean ± SD) | 52.38 ± 14.21 |
Comorbidities (n (%)) | |
Diabetes | 8 (13.8) |
Hypertension | 18 (31) |
Dyslipidemia | 37 (63.8) |
Overweight or obesity | 35 (60.5) |
Characteristics of RA | |
Age of onset (years) | 41[30.14;51.00]ª |
Duration of disease (years) | 10.41[3.16;16.11]ª |
Duration of disease > 10 years (n (%)) | 30(52) |
DAS28-CRP | 4.03[2.95;5.28]ª |
Presence of tender joints (n (%)) | 50 (86) |
NTJ | 6 [2;10]ª |
Presence of swollen joints (n (%)) | 49 (85) |
NSJ | 4 [2;7]ª |
VAS | 5 [3;7]ª |
Presence of morning stiffness (n (%)) | 36(62) |
Duration of morning stiffness (minutes) | 60[30;120]ª |
Presence of nocturnal awakening (n (%)) | 35(60) |
Number of nocturnal awakenings | 2 [2;3]ª |
HAQ | 1.34[0.97;1.50]ª |
Functional disability (n (%)) | 34(92) |
Structural damage (n (%)) | 39(66) |
CRP (mg/L) | 8.38 [2.23;21.52]ª |
Positive RF (n (%)) | 46(87) |
Positive ACPA (n (%)) | 36(73) |